"news" repeating Shkreli's BS from yesterday. Concerted effort to go after the stock. "Street Insider News" is the reporting entity.

Here is what Shkreli tweeted yesterday:

"I do not believe the drug •can• work given its PK and receptor pharmacology profile."

Remember this guy is a notorious short seller, a Wall Street guy not a scientist. Why does anyone take this seriously, when the people running the conference must believe it •can• work, since they gave them one of the last-minute "breaking news" slots?